Skip to main content
Internal Medicine Nephrology

Nephrology

Arrhythmia secondary to abiraterone treatment

A man receiving abiraterone for prostate cancer developed severe hypokalemia, which led to polymorphic ventricular tachycardia and cardiac arrest. It is important to consider iatrogenic causes in cases of arrhythmia.

Dilated cardiomyopathy due to hypocalcemia

Open Access Cardiomyopathy Case Study

Heart failure with reduced ejection fraction due to dilated cardiomyopathy in a patient with hypocalcemic cardiomyopathy, secondary to primary hypoparathyroidism.

Making the most of GDMT in heart failure

Open Access Hypotension Review

The delayed titration of guideline-directed medical therapy is complex and often results in poor prognosis for heart failure patients. Are you using GDMT in the most effective way?

Fabry disease: the promise of personalized medicine

Open Access Fabry Disease Review

Learn about Fabry disease, a rare disease that can have renal, cardiovascular, neurological, cutaneous, and ophthalmic manifestations. Discover the ways in which it may be possible to personalize treatment.

Preventing and treating stroke in type 2 diabetes

Open Access Type 2 Diabetes Review

The risks of ischemic and hemorrhagic stroke and poor neurological outcomes after stroke are increased in people with type 2 diabetes. Explore how to manage the hyperacute stroke stage and prevent CV disease.

Our tailored content service will keep you up to date…

Receive newsletters curated for the busy specialist by our expert editorial team

Arrhythmia secondary to abiraterone treatment

A man receiving abiraterone for prostate cancer developed severe hypokalemia, which led to polymorphic ventricular tachycardia and cardiac arrest. It is important to consider iatrogenic causes in cases of arrhythmia.

Dilated cardiomyopathy due to hypocalcemia

Open Access Cardiomyopathy Case Study

Heart failure with reduced ejection fraction due to dilated cardiomyopathy in a patient with hypocalcemic cardiomyopathy, secondary to primary hypoparathyroidism.

Adalimumab causes kidney injury in pediatric Crohn’s disease

Kidney injury is a known side-effect of using adalimumab to treat inflammatory bowel diseases, but has rarely been seen in children. Timely withdrawal can significantly reduce kidney damage but it is irreversible in some cases.

Current Reviews

Antibiotic-loaded cement in total joint arthroplasty: a comprehensive review

Antibiotic Orthopaedic Surgery

This review evaluates the decision-making framework for using antibiotic-loaded cement (ALC) in the management of prosthetic joint infection (PJI). Drawing on available literature, we offer orthopaedic surgeons a guided discussion on several …

The current use of proteomics and metabolomics in glomerulonephritis: a systematic literature review

Open Access Glomerulonephritis Systematic Reviews

Kidney disease is increasingly becoming a significant worldwide health burden [ 1 ]. The global all-age chronic kidney disease (CKD) mortality increased by 41.5% between 1990 and 2019 [ 2 , 3 ]. There is a growing, unified acknowledgement of an …

Approach to simple kidney cysts in children

Open Access Polycystic Kidney Disease Review

The finding of a simple kidney cyst in a child can pose a diagnostic and management challenge for pediatric nephrologists, urologists, and primary care providers. The reported prevalence varies from 0.22 to 1% in large ultrasonography-based series …

Overview of F18-FDG uptake patterns in retroperitoneal pathologies: imaging findings, pitfalls, and artifacts

The retroperitoneum, a confined complex intra-abdominal space with defined anatomic fascial layers, can host a variety of pathologic processes. Certain pathologies originate in the retroperitoneum, while for others, it serves as a route for …

Vodcasts | Case Scenarios (Link opens in a new window)

Expert guidance on the multidisciplinary approach to identifying and managing chronic kidney disease in patients with type 2 diabetes, plus patient scenarios to assist your decision-making and put the latest clinical guidelines into context.

This program is not available to users in the UK and US.

Supported by:
  • Novo Nordisk A/S
Developed by: Springer Healthcare IME

eLearning | Infographics (Link opens in a new window)

An independent educational program featuring simulated patient consultations. Make knowledge-based decisions on diagnosis and management of CKD with and without co-morbidities, and learn from experts Kevin Fernando and David Wheeler.

Supported by:
  • AstraZeneca
Developed by: Springer Healthcare IME

Further Reading

Dual-loss of PBRM1 and RAD51 identifies hyper-sensitive subset patients to immunotherapy in clear cell renal cell carcinoma

Open Access Kidney Cancer Research

Renal cell carcinoma (RCC) is one of the top ten most frequent cancer types worldwide, affecting over 400,000 patients per year [ 1 ]. Among RCC, clear cell renal cell carcinoma (ccRCC) is the most common subtype, accounting for 70–80% of cases [ 2 …,

Hyperkalemia Recurrence Following Medical Nutrition Therapy in Patients with Stage 3–4 Chronic Kidney Disease: The REVOLUTIONIZE I Real-World Study

Open Access Hyperkalemia Original Research

This article is published with digital features, including an infographic, to facilitate understanding of the article. To view digital features for this article, go to https://doi.org/10.6084/m9.figshare.25352206 .

The role of aetiology in cardiac manifestations of chronic kidney disease: the CPH-CKD ECHO study

Open Access Chronic Kidney Disease Original paper

The comorbidity of cardiovascular disease (CVD) in relation to chronic kidney disease (CKD) is alarmingly high [ 1 ], as it currently constitutes the most common cause of death in the patient group [ 2 ]. Hence, the KDIGO guidelines recommend that …

The current use of proteomics and metabolomics in glomerulonephritis: a systematic literature review

Open Access Glomerulonephritis Systematic Reviews

Kidney disease is increasingly becoming a significant worldwide health burden [ 1 ]. The global all-age chronic kidney disease (CKD) mortality increased by 41.5% between 1990 and 2019 [ 2 , 3 ]. There is a growing, unified acknowledgement of an …